Literature DB >> 15010455

The second intracellular loop of the glycine transporter 2 contains crucial residues for glycine transport and phorbol ester-induced regulation.

Amparo Fornés1, Enrique Núñez, Carmen Aragón, Beatriz López-Corcuera.   

Abstract

Na+ and Cl(-)-coupled glycine transporters control the availability of glycine neurotransmitter in the synaptic cleft of inhibitory glycinergic pathways. In this report, we have investigated the involvement of the second intracellular loop of the neuronal glycine transporter 2 (GLYT2) on the protein conformational equilibrium and the regulation by 4alpha-phorbol 12 myristate 13-acetate (PMA). By substituting several charged (Lys-415, Lys-418, and Lys-422) and polar (Thr-419 and Ser-420) residues for different amino acids and monitoring plasma membrane expression and kinetic behavior, we found that residue Lys-422 is crucial for glycine transport. The introduction of a negative charge in 422, and to a lower extent in neighboring N-terminal residues, dramatically increases transporter voltage dependence as assessed by response to high potassium depolarizing conditions. In addition, [2-(trimethylammonium)ethyl] methanethiosulfonate accessibility revealed a conformational connection between Lys-422 and the glycine binding/permeation site. Finally, we show that the mutation of positions Thr-419, Ser-420, and mainly Lys-422 to acidic residues abolishes the PMA-induced inhibition of transport activity and the plasma membrane transporter internalization. Our results establish a new structural basis for the action of PMA on GLYT2 and suggest a complex nature of the PMA action on this glycine transporter.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15010455     DOI: 10.1074/jbc.M401337200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.

Authors:  Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  AAPS J       Date:  2005-10-27       Impact factor: 4.009

2.  P2Y purinergic regulation of the glycine neurotransmitter transporters.

Authors:  Esperanza Jiménez; Francisco Zafra; Raquel Pérez-Sen; Esmerilda G Delicado; Maria Teresa Miras-Portugal; Carmen Aragón; Beatriz López-Corcuera
Journal:  J Biol Chem       Date:  2011-01-18       Impact factor: 5.157

3.  A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2.

Authors:  Cecilio Giménez; Gonzalo Pérez-Siles; Jaime Martínez-Villarreal; Esther Arribas-González; Esperanza Jiménez; Enrique Núñez; Jaime de Juan-Sanz; Enrique Fernández-Sánchez; Noemí García-Tardón; Ignacio Ibáñez; Valeria Romanelli; Julián Nevado; Victoria M James; Maya Topf; Seo-Kyung Chung; Rhys H Thomas; Lourdes R Desviat; Carmen Aragón; Francisco Zafra; Mark I Rees; Pablo Lapunzina; Robert J Harvey; Beatriz López-Corcuera
Journal:  J Biol Chem       Date:  2012-06-29       Impact factor: 5.157

Review 4.  SLC6 transporters: structure, function, regulation, disease association and therapeutics.

Authors:  Akula Bala Pramod; James Foster; Lucia Carvelli; L Keith Henry
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

5.  Glycine transporter dimers: evidence for occurrence in the plasma membrane.

Authors:  Ingo Bartholomäus; Laura Milan-Lobo; Annette Nicke; Sébastien Dutertre; Hanne Hastrup; Alok Jha; Ulrik Gether; Harald H Sitte; Heinrich Betz; Volker Eulenburg
Journal:  J Biol Chem       Date:  2008-02-05       Impact factor: 5.157

6.  Constitutive endocytosis and turnover of the neuronal glycine transporter GlyT2 is dependent on ubiquitination of a C-terminal lysine cluster.

Authors:  Jaime de Juan-Sanz; Enrique Núñez; Beatriz López-Corcuera; Carmen Aragón
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

7.  PKC-Dependent GlyT1 Ubiquitination Occurs Independent of Phosphorylation: Inespecificity in Lysine Selection for Ubiquitination.

Authors:  Susana P Barrera; Vicente Castrejon-Tellez; Margarita Trinidad; Elisa Robles-Escajeda; Javier Vargas-Medrano; Armando Varela-Ramirez; Manuel Miranda
Journal:  PLoS One       Date:  2015-09-29       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.